Seeing Is Believing
with an average price target of $7.27. This is a potential upside of $7.27 (0%) from yesterday's end of day stock price of $0.
Gemphire Therapeutics's activity chart (see below) currently has 4 price targets and 3 ratings on display.
Analysts average stock forecasts to be materialized ratio is 54.17% with an average time for these price targets to be met of 78.5 days.
Most recent stock forecast was given by MATTHEW ANDREWS from on 13-Aug-2018. First documented stock forecast 30-Aug-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$-5.5 (-73.33%)
$18
6 years 3 months 11 days ago
(13-Aug-2018)
3/4 (75%)
$0.34 (20.48%)
130
Hold
$2
$-5.5 (-73.33%)
$30
6 years 3 months 14 days ago
(10-Aug-2018)
1/3 (33.33%)
$14.2 (165.52%)
27
What is GEMP (Gemphire Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GEMP (Gemphire Therapeutics) with a proven track record?
Which analyst has the current lower performing score on GEMP (Gemphire Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GEMP (Gemphire Therapeutics)?
Which analyst is the currently most bullish on GEMP (Gemphire Therapeutics)?
Which analyst is the currently most reserved on GEMP (Gemphire Therapeutics)?